← Back to directory

Thor Ueland

Researcher Next ID · RN-021727

Researcher · Medicine

Oslo University Hospital

Oslo, Norway

Not currently recruitingFunding unknown
Works count
770
Citation count
29,019
H-index
83
i10-index
499

Research interests

Medicine
Neuroscience
Immunology and Microbiology
Biochemistry, Genetics and Molecular Biology
Cardiac Fibrosis and Remodeling
Adipokines, Inflammation, and Metabolic Diseases
Tryptophan and brain disorders
Atherosclerosis and Cardiovascular Diseases
Bone Metabolism and Diseases

Publications

  • Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction

    Journal of the American College of Cardiology · 2021 · https://doi.org/10.1016/j.jacc.2021.02.049

  • Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients

    Proceedings of the National Academy of Sciences · 2020 · https://doi.org/10.1073/pnas.2010540117

  • sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T

    Journal of the American College of Cardiology · 2018 · 10.1016/j.jacc.2018.08.2165

  • Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts

    Journal of the American College of Cardiology · 2018 · 10.1016/j.jacc.2017.12.057

  • Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure

    Circulation · 2018 · https://doi.org/10.1161/circulationaha.117.031560

  • Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial

    European Heart Journal · 2016 · 10.1093/eurheartj/ehw171

  • Microbiota‐dependent metabolite trimethylamine‐N‐oxide is associated with disease severity and survival of patients with chronic heart failure

    Journal of Internal Medicine · 2014 · https://doi.org/10.1111/joim.12328

  • Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart Failure

    Circulation Heart Failure · 2013 · 10.1161/circheartfailure.112.000129

  • Inflammatory Cytokines in Heart Failure: Mediators and Markers

    Cardiology · 2012 · 10.1159/000338166

  • Dickkopf-1 Enhances Inflammatory Interaction Between Platelets and Endothelial Cells and Shows Increased Expression in Atherosclerosis

    Arteriosclerosis Thrombosis and Vascular Biology · 2009 · 10.1161/atvbaha.109.189761

  • Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study

    European Respiratory Journal · 2009 · 10.1183/09031936.00088209

  • Circulating Osteoprotegerin Levels and Long-Term Prognosis in Patients With Acute Coronary Syndromes

    Journal of the American College of Cardiology · 2008 · https://doi.org/10.1016/j.jacc.2007.09.058

  • Increased Expression of Visfatin in Macrophages of Human Unstable Carotid and Coronary Atherosclerosis

    Circulation · 2007 · https://doi.org/10.1161/circulationaha.106.665893

  • Medical Observation, Compared with Parathyroidectomy, for Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized Trial

    The Journal of Clinical Endocrinology & Metabolism · 2007 · 10.1210/jc.2006-1836

  • Systemic inflammation in heart failure – The whys and wherefores

    Heart Failure Reviews · 2006 · 10.1007/s10741-006-9196-2

  • Enhanced T-Cell Expression of RANK Ligand in Acute Coronary Syndrome

    Arteriosclerosis Thrombosis and Vascular Biology · 2006 · 10.1161/01.atv.0000204334.48195.6a

  • Dysregulated Osteoprotegerin/RANK Ligand/RANK Axis in Clinical and Experimental Heart Failure

    Circulation · 2005 · 10.1161/01.cir.0000165119.62099.14

  • Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction

    Journal of the American College of Cardiology · 2004 · 10.1016/j.jacc.2004.06.076

  • Raised Plasma Levels of Tumor Necrosis Factor α in Patients With Depression

    Journal of Ect · 2003 · 10.1097/00124509-200312000-00002

  • Immunomodulating Therapy With Intravenous Immunoglobulin in Patients With Chronic Heart Failure

    Circulation · 2001 · 10.1161/01.cir.103.2.220

  • Decreased Bone Formative and Enhanced Resorptive Markers in Human Immunodeficiency Virus Infection: Indication of Normalization of the Bone-Remodeling Process during Highly Active Antiretroviral Therapy1

    The Journal of Clinical Endocrinology & Metabolism · 1999 · https://doi.org/10.1210/jcem.84.1.5417

  • Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure

    Journal of the American College of Cardiology · 1999 · 10.1016/s0735-1097(99)00495-7

  • Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina

    Circulation · 1999 · https://doi.org/10.1161/01.cir.100.6.614

  • Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

    The American Journal of Cardiology · 1999 · 10.1016/s0002-9149(98)00872-8

  • Elevated Circulating Levels of C-C Chemokines in Patients With Congestive Heart Failure

    Circulation · 1998 · https://doi.org/10.1161/01.cir.97.12.1136

Current projects

    No projects listed.